Juliana P Vago Selected Research

Juliana P Vago Research Topics

Disease

18	Inflammation (Inflammations) 10/2023 - 08/2012
3	Leishmaniasis 02/2024 - 01/2017
3	Arthritis (Polyarthritis) 01/2023 - 01/2016
3	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2016
2	Infections 02/2024 - 01/2017
2	Pain (Aches) 01/2023 - 01/2022
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Pneumococcal Pneumonia 01/2022 - 01/2016
1	Root Resorption 11/2023
1	Endotoxemia 01/2023
1	Joint Diseases (Joint Disease) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Disease Progression 01/2022
1	Human Influenza (Influenza) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Pneumococcal Infections 01/2021
1	Pleurisy (Pleuritis) 01/2019
1	Gout 01/2017
1	Lung Injury 01/2016
1	Experimental Arthritis 01/2016

Drug/Important Bio-Agent (IBA)

8	Annexin A1IBA 02/2024 - 08/2012
5	PlasminogenIBA 10/2023 - 10/2014
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
5	GlucocorticoidsIBA 01/2022 - 08/2012
4	Fibrinolysin FDA Link 10/2023 - 10/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2016
3	CytokinesIBA 01/2016 - 05/2015
2	FibrinIBA 01/2023 - 10/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2023
2	LipidsIBA 01/2021 - 01/2016
2	AntigensIBA 01/2021 - 01/2016
2	CaspasesIBA 01/2017 - 05/2015
2	RolipramIBA 01/2017 - 01/2016
2	Uric Acid (Urate)IBA 01/2017 - 02/2016
1	annexin A1 peptide (2-26)IBA 02/2024
1	estropipate (Ogen)FDA LinkGeneric 01/2023
1	U 0126 (UO 126)IBA 01/2022
1	VaccinesIBA 01/2022
1	c-Mer Tyrosine KinaseIBA 11/2021
1	tyrosine receptor (receptor, tyrosine)IBA 11/2021
1	imidazoleIBA 01/2021
1	lipoxin A4IBA 01/2021
1	angiotensin I (1-7)IBA 01/2021
1	SphingolipidsIBA 01/2019
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Cyclic AMP (AMP, Cyclic)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2017
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2017
1	Phosphodiesterase 4 InhibitorsIBA 01/2017
1	sivelestatIBA 02/2016
1	Pancreatic Elastase (Elastase)IBA 02/2016
1	Secretory Leukocyte Peptidase InhibitorIBA 02/2016
1	ElafinIBA 02/2016
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2016
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Etanercept (Enbrel)FDA Link 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	AdipokinesIBA 01/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2015
1	Caspase 3 (Caspase-3)IBA 08/2012
1	Neutralizing AntibodiesIBA 08/2012

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2016
1	Tooth Movement Techniques 11/2023
1	Palatal Expansion Technique 11/2023
1	Intra-Articular Injections 01/2023
1	Punctures 01/2023
1	Pain Management 01/2023
1	Ligation 01/2023